Nukkleus Inc. Files Definitive Proxy Statement

TL;DR

Nukkleus Inc. filed its proxy statement, shareholders get to vote soon.

AI Summary

Nukkleus Inc. filed a definitive proxy statement (DEF 14A) on September 30, 2024, for the fiscal year ending September 30, 2024. The company, formerly known as Brilliant Acquisition Corp. until September 9, 2019, is incorporated in Delaware and headquartered in Jersey City, NJ. The filing pertains to the company's proxy solicitation under the Securities Exchange Act of 1934.

Why It Matters

This filing is a standard regulatory requirement for public companies, providing shareholders with information necessary to vote on company matters at their annual meeting.

Risk Assessment

Risk Level: low — This is a routine regulatory filing and does not contain new financial or operational information that would inherently increase risk.

Key Numbers

• 0930 — Fiscal Year End (Indicates the end of the reporting period for the company's financial statements.)

Key Players & Entities

• Nukkleus Inc. (company) — Registrant
• Brilliant Acquisition Corp. (company) — Former company name
• 0001213900-24-083424 (dollar_amount) — Accession Number
• 20241011 (dollar_amount) — Conformed Period of Report
• 0930 (dollar_amount) — Fiscal Year End

FAQ

Key Financial Figures

• $5,500 — ompany in consideration of a payment of $5,500. RECORD DATE Stockholders of record
• $437,500 — issory Notes in the principal amount of $437,500 and exercise of a Stock Purchase Warran
• $515,000 — issory Notes in the principal amount of $515,000 and exercise of a Stock Purchase Warran

Filing Documents

• ea0214847-02.htm (DEF 14A) — 1225KB
• 0001213900-24-083424.txt ( ) — 1227KB

From the Filing

DEF 14A 1 ea0214847-02.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ Schedule 14A ___________________ Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant   Filed by a party other than the Registrant   Check the appropriate box:   Preliminary Proxy Statement   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2))   Definitive Proxy Statement   Definitive Additional Materials   Soliciting Material under § 240.14a -12 Nukkleus Inc. (Name of Registrant as Specified In Its Charter) ______________________________________________________________ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):   No fee required   Fee paid previously with preliminary materials.   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a -6 (i)(1) and 0 -11   Nukkleus Inc. 2024 NOTICE OF ANNUAL MEETING AND PROXY STATEMENT October 11, 2024 at 10:00 a.m. Eastern Time Virtual Meeting to be Held by Webcast   Nukkleus Inc. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON OCTOBER 11, 2024 The 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of Nukkleus Inc. (“Nukkleus” or the “Company”) will be held virtually by webcast, on October 11, 2024, at 10:00 a.m. Eastern Time, to consider the below proposals. As in recent years, in order to provide safe and expanded access, improved communication, reduced environmental impact and cost savings, the Annual Meeting will be held in a virtual meeting format at https://www.cstproxy.com/nukk/2024 . 1.        To elect the seven director nominees named in the Proxy Statement to hold office until the next annual meeting of stockholders and until their successors are duly elected and qualified; 2.        To ratify the appointment of GreenGrowth CPAs as the Company’s independent auditors for the fiscal year ending September 30, 2024; 3.        To approve an amendment to our amendment and restated certificate of incorporation to effect a reverse stock split at a ratio not less than 1 -for-2 and not greater than 1 -for-30 , with the exact ratio to be set within that range at the discretion of our board of directors before September 30, 2025 without further approval or authorization of our stockholders (the “Reverse Split Proposal”). The board of directors may alternatively elect to abandon such proposed amendment and not effect the reverse stock split authorized by stockholders, in its sole discretion; 4.        To approve and ratify the 2024 Equity Incentive Plan and the authorization of 10,000,000 shares of common stock for issuance thereunder; 5.        To approve an amendment to our amended and restated certificate of incorporation to increase the number of authorized shares of common stock from 40,000,000 to 150,000,000; and 6.        To act on such other matters as may properly come before the meeting or any adjournment thereof. BECAUSE OF THE SIGNIFICANCE OF THESE PROPOSALS TO THE COMPANY AND ITS STOCKHOLDERS, IT IS VITAL THAT EVERY STOCKHOLDER VOTE AT THE ANNUAL MEETING IN PERSON OR BY PROXY. These proposals are fully set forth in the accompanying Proxy Statement which you are urged to read thoroughly. For the reasons set forth in the Proxy Statement, your Board of Directors recommends a vote “FOR” the directors set forth in Proposal 1 and “FOR” Proposals 2, 3, 4, 5 and 6. A list of all stockholders entitled to vote at the Annual Meeting will be available at the principal office of the Company during usual business hours for examination by any stockholder for any purpose germane to the Annual Meeting for 10 days prior to the date thereof. Stockholders are cordially invited to attend the Annual Meeting. In order to provide safe and expanded access, improved communication, reduced environmental impact and cost savings we are pleased that for this year’s Annual Meeting we will again be hosting a completely virtual meeting of stockholders, which will be conducted solely online via live webcast. You will be able to attend and participate in the Annual Meeting online and submit your questions prior to and during the meeting by visiting: h ttps:/

View Full Filing

View this DEF 14A filing on SEC EDGAR